- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01437917
NOMAC : New Tools for Managing the Fate of Cereal Nutrients in the Gut : Effects of Amylose Content on Glycemic Index. (NOMAC)
May 15, 2012 updated by: Rennes University Hospital
The consumption of cereals-based foods with low glycemic indexes, high micronutrients and fibers contents are highly recommended.
The target of this work is to provide new solutions for cereal based foods: the knowledge and understanding on the in vivo fate will be used to define structural features to gain in foods.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bretagne
-
Rennes, Bretagne, France, 35033
- Rennes University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy individual,
- Age between 19-65 years
- With normal food habits with at least 2 main meals per day
- Non smoking
- Having filled the consent form
Exclusion Criteria:
- BMI > 25 kg/m2,
- Diabetes or any illness susceptible to alter
- Coeliac disease
- Past history of intestinal diseases.
- Treatment susceptible of modifying glycemia.
- Allergy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Bread with 20% amylose content
|
20% amylose bread
|
|
Experimental: Bread with 10% amylose content
|
10% amylose bread
|
|
Experimental: carbohydrates
50g of carbohydrates ingested with 400 ml of water
|
50g of carbohydrates ingested with 400 ml of water
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Glycemic index for each bread
Time Frame: 2 hours
|
To compare the glycemic index of breads made with different amylose content.
(S1 to S6) A total of 6 visits.
In each visit, blood samples will be taken for measurement of glycemia and insulinemia over 2 hours after ingestion of 50 of carbohydrates ingested with 400 ml of water.
|
2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
AUC for insulinemia for the 2 hours following the ingestion of each bread.
Time Frame: 2 hours
|
To compare the AUC for insulinemia for the 2 hours following the ingestion of each bread.
|
2 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Fabrice BONNET, MD, Rennes University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2011
Primary Completion (Actual)
April 1, 2012
Study Completion (Actual)
April 1, 2012
Study Registration Dates
First Submitted
September 20, 2011
First Submitted That Met QC Criteria
September 20, 2011
First Posted (Estimate)
September 21, 2011
Study Record Updates
Last Update Posted (Estimate)
May 16, 2012
Last Update Submitted That Met QC Criteria
May 15, 2012
Last Verified
May 1, 2012
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- LOC/11-05 - NOMAC
- 2011-A00517-34 (Other Identifier: ID RCB)
- 11/19-808 (Other Identifier: CPP Ouest V)
- B110607-50 (Other Identifier: AFSSAPS)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.